Sponsorizzato
Genetic Testing Fuels Growth in Inherited Cardiomyopathy Diagnosis
The Global Dilated Cardiomyopathy (DCM) Therapeutics Market is poised for robust growth, projected to increase from USD 1.1 billion in 2023 to USD 1.7 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period. The increasing burden of heart failure globally, advances in genetic testing, and expanding access to targeted therapies are major forces driving...
0 Commenti 0 condivisioni 440 Views 0 Anteprima
Sponsorizzato
Sponsorizzato
Sponsorizzato